Mapping commonalities and differences in approaches for testing and assessment of endocrine disruptors within the EU and among relevant international trading partners

The objective of this study is to compare approaches for the regulatory screening, testing and assessments of substances for the endocrine disrupting properties within the European Union (EU) and among relevant international trading partners, as well as the results of these approaches, in order to establish commonalities and differences and assess the drivers for these differences